CYP19A1 and Anxiety: This longitudinal study aimed to determine whether frailty levels, anxiety and depressive symptoms, and sleep quality were reduced in patients with localized breast cancer treated with aromatase inhibitors after 3 months of combined and supervised physical exercise and six group health education sessions.